The prevalence of sickle cell disease (SCD) is a challenge for the healthcare systems around the world. There are very limited treatment options and, as yet, no effective therapies that address the underlying cause of the disease. Read More
The Compounding Quality Act, part of the Drug Quality and Security Act, signed into law last month, creates a volunteer registration of “outsourcing facilities” that will be subject to scrutiny by the FDA, including routine inspections. Read More
